Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 701–800 of 1,004
Li, J., Yang, R., Dong, Y., Chen, M., Wang, Y., & Wang, G. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1046-x · Cited by 52
RetractedEmbryonic Chicken (Gallus gallus domesticus) as a Model of Cardiac Biology and Development
Vilches-Moure, J. G. (2019) · Comparative Medicine · doi:10.30802/aalas-cm-18-000061 · Cited by 68
miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
Xi, Q., Chen, Y., Yang, G.-Z., Zhang, J.-Y., Zhang, L.-J., Guo, X.-D., Zhao, J.-Y., Xue, Z.-Y., Li, Y., & Zhang, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00890 · Cited by 47
“The zinc finger E-box-binding homeobox 1 (ZEB1) is a crucial EMT activator in several cancers (15, 16), closely related to tumor initiation and malignant progression (13, 17), which can also regulate CD47 (18).”
BackgroundlncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
Zhang, S., Li, J., Gao, H., Tong, Y., Li, P., Wang, Y., Du, L., & Wang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.656554 · Cited by 51
“EMT is an important biological event during human cancer progression (De Craene and Berx, 2013; Pastushenko et al., 2018; Pastushenko and Blanpain, 2019).”
BackgroundYe, P., Feng, L., Shi, S., & Dong, C. (2022) · Cancers · doi:10.3390/cancers14092101 · Cited by 55
Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
Sarrand, J., & Soyfoo, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914481 · Cited by 52
Ebrahimi, N., Manavi, M. S., Faghihkhorasani, F., Fakhr, S. S., Baei, F. J., Khorasani, F. F., Zare, M. M., Far, N. P., Rezaei‐Tazangi, F., Ren, J. T., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10162-7 · Cited by 54
“Inhibitor of differentiation (ID) proteins, E47 and E12, TWIST-1 and -2, are among those that play critical roles in the advancement of EMT [18, 49].”
Snider, N. T., Altshuler, P. J., Wan, S., Welling, T. H., Cavalcoli, J. D., & Omary, M. B. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1167 · Cited by 49
“…not abundant in normal human tissues but are induced in HCV-associated cirrhosis and HCC. Pre-mRNA splicing factors and events are known to be deregulated in human cancers (David and Manley, 2010; Singh and Cooper, 2012; De Craene and Berx, 2013), including HCC (Chan et al., 2014; Qi et al., 2014).”
BackgroundMethodSilencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells
Shi, Z., Wu, D., Tang, R., Li, X., Chen, R., Xue, S., Zhang, C., & Sun, X. (2016) · Journal of Biosciences · doi:10.1007/s12038-016-9603-3 · Cited by 49
“Additionally, the core EMT regulatory factors, such as Snail, Slug and Twist have been proved to be inversely correlated with the expression of E-cadherin (De Craene and Berx 2013; Dalvi et al. 2009; Lander et al. 2011; Diaz et al. 2014).”
Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells
Zhou, Z., Wang, S., Song, C., & Hu, Z. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s102422 · Cited by 49
“Reduction or a loss of E-cadherin expression has a crucial role in tumor progression to invasive cancer and is also one of the well-established hallmarks of EMT.”
InfluentialZhang, H., Sun, J., Yan, L., & Zhao, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.035 · Cited by 49
Cai, Q., Jin, L., Wang, S., Zhou, D., Wang, J., Tang, Z., & Quan, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.18204 · Cited by 49
“E-cadherin, a tumor suppressor in cancer development, is regulated by multiple enzymes involving epigenetic modifications [29].”
BackgroundLiu, Y., Zhou, H., Zhu, R., Ding, F., Li, Y., Cao, X., & Liu, Z. (2017) · Oncogene · doi:10.1038/onc.2017.370 · Cited by 53
PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2
Shen, H., Zhan, M., Zhang, Y., Huang, S., Xu, S., Huang, X., He, M. Y., Yao, Y., Man, M., & Wang, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0107-3 · Cited by 54
Jiang, Y., Jiao, Y., Liu, Y., Zhang, M., Wang, Z., Li, Y., Li, T., Zhao, X., & Wang, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030844 · Cited by 52
Krzysiek-Mączka, G., Targosz, A., Szczyrk, U., Strzałka, M., Śliwowski, Z., Brzozowski, T., Czyż, J., & Ptak‐Belowska, A. (2018) · Helicobacter · doi:10.1111/hel.12538 · Cited by 52
Zhu, L., Yang, N., Du, G., Li, C., Liu, G., Liu, S., Xu, Y., Di, Y., Pan, W., & Li, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26762 · Cited by 49
“Activation of the Wnt/β‐catenin signaling is one of the most important inducers of EMT.(26) GSK‐3beta suppresses HCC cell dissociation in vitro by upregulating epithelial junction proteins and inhibiting the Wnt/β‐catenin signaling pathway.”
BackgroundInfluentialZhang, J., Chu, D., Kawamura, T., Tanaka, K., & He, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27914 · Cited by 49
“EMT, which is characterized as the downregulation of epithelial markers and the upregulation of mesench- ymal markers, is a crucial step for cancer cell migration and invasion in various cancer types (De Craene & Berx, 2013).”
BackgroundXie, J., Lin, L., Huang, X., Gan, R.-H., Ding, L.-C., Su, B.-H., Zhao, Y., Lu, Y., & Zheng, D. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.36407 · Cited by 51
“Tumor cells need to undergo partial or full epithelial–mesenchymal transition and are transformed into migrating and invasive cells [23].”
BackgroundDong, C., Zhang, J., Fang, S., & Liu, F. (2020) · Cell Division · doi:10.1186/s13008-020-00061-6 · Cited by 52
Bahar, E., Kim, J., Kim, H.-S., & Yoon, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207613 · Cited by 53
Emerging Roles of SKP2 in Cancer Drug Resistance
Wu, T., Gu, X., & Cui, H. (2021) · Cells · doi:10.3390/cells10051147 · Cited by 51
“Epithelial–mesenchymal transition (EMT) is a biological process in which polarized phenotype epithelial cells transform into mesenchymal cells through loss of epithelial cell–cell junctions and actin cytoskeleton reorganization [105].”
BackgroundImodoye, S. O., Adedokun, K. A., Muhammed, A. O., Bello, I. O., Muhibi, M. A., Oduola, T., & Oyenike, M. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762817 · Cited by 53
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Hamidi, A. A., Taghehchian, N., Basirat, Z., Zangouei, A. S., & Moghbeli, M. (2022) · Biomarker Research · doi:10.1186/s40364-022-00382-4 · Cited by 48
Chen, D., Gassenmaier, M., Maruschke, M., Riesenberg, R., Pohla, H., Stief, C. G., Zimmermann, W., & Büchner, A. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.08.052 · Cited by 50
Ha, J. H., Ward, J. D., Radhakrishnan, R., Jayaraman, M., Song, Y. S., & Dhanasekaran, D. N. (2016) · Oncotarget · doi:10.18632/oncotarget.9224 · Cited by 50
Gauck, D., Keil, S., Niggemann, B., Zänker, K. S., & Dittmar, T. (2017) · BMC Cancer · doi:10.1186/s12885-017-3509-9 · Cited by 48
“and SNAIL belong to a family of well-known EMT transcription factors [52], whereby ZEB expression is induced by SNAIL [53].”
BackgroundEmerging roles of epithelial-mesenchymal transition in hematological malignancies
Chen, S., Liao, T., & Yang, M. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0440-6 · Cited by 56
“EMT-TFs often function as repressors for epithelial genes and activators for mesenchymal genes [7, 13, 14].”
BackgroundControlling metastatic cancer: the role of phytochemicals in cell signaling
Kapinová, A., Kubatka, P., Líšková, A., Baranenko, D., Kružliak, P., Matta, M., Büsselberg, D., Malicherová, B., Zulli, A., Kwon, T. K., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02892-5 · Cited by 49
Pyko, J., Rosemann, J., Krauspe, V., Kappler, M., Eckert, A. W., Hämmerle, M., & Gutschner, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186835 · Cited by 53
“Mechanistically, ESRP1/2 regulate epithelium-specific splicing by binding of UGG- or GGU-rich sequences that are known as ESRP binding splicing enhancer (EBSE) and ESRP binding splicing inhibitor (EBSI) [42,134].”
BackgroundInfluentialEmergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Chaudhuri, A., Kumar, D. N., Dehari, D., Singh, S. P., Kumar, P., Bolla, P. K., Kumar, D. K., & Agrawal, A. K. (2022) · Pharmaceuticals · doi:10.3390/ph15050542 · Cited by 54
“During the local invasion and intravasation, the TNBC cells experience various phenomena like epithelial-to-mesenchymal transition (EMT), the disintegration of cell-cell junctions, overexpression of mesenchymal genes, and reduced expression of epithelial markers [16].”
BackgroundThe Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition
Feng, J. Q., Hu, S., Liu, K., Sun, G., & Zhang, Y. (2022) · Cells · doi:10.3390/cells11131981 · Cited by 53
“Herein, we emphasize that the same transcription factors can perform functions at different levels, including transcription and translation, expression of noncoding RNAs, alternative splicing, and repression and activation of protein stabilization [61].”
BackgroundSreekumar, R., AlSaihati, H., Emaduddin, M., Moutasim, K. A., Mellone, M., Patel, A., Kılıç, S., Çetįn, M., Erdemir, S., Navio, M. S., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12965 · Cited by 51
Self-citationCancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Benboubker, V., Boivin, F., Dalle, S., & Caramel, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873116 · Cited by 55
“This process is driven by intense transcriptional, epigenetic and translational reprogramming, involving EMT-associated transcription factors (EMT-TFs) (33, 34).”
BackgroundDevelopmental Pathways Hijacked by Osteosarcoma
Mortus, J., Zhang, Y., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_5 · Cited by 49
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis
Lin, X., Chen, L., Yao, Y., Zhao, R., Cui, X., Chen, J., Hou, K., Zhang, M., Su, F., Chen, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4107 · Cited by 47
“Therefore, inhibition of NFκB could reverse EMT in Ras-transformed mammary epithelial cells [37].”
miR-204-5p expression in colorectal cancer: an autophagy-associated gene
Sümbül, A. T., Göğebakan, B., Ergün, S., Yengil, E., Batmacı, C. Y., Tonyalı, Ö., & Yaldız, M. (2014) · Tumor Biology · doi:10.1007/s13277-014-2596-3 · Cited by 47
“The role of autophagy in cancer is one that has been highly researched and reviewed [1–4].”
BackgroundCirculating Tumor Cells in Prostate Cancer
Hu, B. R., Rochefort, H. M., & Goldkorn, A. (2013) · Cancers · doi:10.3390/cancers5041676 · Cited by 52
“Much of the pathology of metastasis is unclear, but emerging data points to epithelial mesenchymal transition (EMT) being involved [11,12].”
BackgroundTwist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1
Qian, J., Luo, Y., Gu, X., Wang, Z., & Wang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077625 · Cited by 48
ZNF281/ZBP-99: a new player in epithelial–mesenchymal transition, stemness, and cancer
Hahn, S., & Hermeking, H. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1160-3 · Cited by 53
“Thereby, EMT promotes motility and invasion, and plays an important role in embryonic development, as it contributes to tissue modeling events, such as gastrulation (mesoderm formation), development of the prevalvular mesenchyme in the heart, formation of neural crest cells and secondary palates, the regression of the…”
BackgroundPan, H.-C., Lai, D., Lan, K., Shen, C.-C., Wu, S., Chiu, C., Wang, K.-B., & Sheu, M. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt243 · Cited by 49
“Emerging evidence suggests that epithelial-to-mesenchymal transition (EMT) leads to increased tumor formation, tissue invasiveness and tumor dissemination (1,2,4).”
BackgroundPrometastatic mechanisms of CAF-mediated EMT regulation in pancreatic cancer cells
Shan, T., Chen, S., Chen, X., Lin, W. R., Li, W., Ma, J., Wu, T., Ji, H. L., Li, Y., Cui, X., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3779 · Cited by 49
“The EMT core transcription factors, Snail1 and Snail2, are able to inhibit the transcription of E-cadherin by directly binding to E-boxes on the E-cadherin promoter (2,15).”
InfluentialChoupani, J., Mansoori Derakhshan, S., Bayat, S., Alivand, M. R., & Shekari Khaniani, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26302 · Cited by 51
“These TFs cooperate in activation and repression of target genes and also in the expression of each other (De Craene & Berx, 2013; Peinado et al., 2007).”
BackgroundmiR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer
Chen, X., Luo, H., Li, X., Xia, T., Peng, B., Liu, S., Zhan, T., Wan, Y.-Y., Chen, W., Li, Y., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy074 · Cited by 49
An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
Coopes, A., Henry, C. E., Llamosas, E., & Ford, C. E. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0112 · Cited by 52
Fan, L., Chen, Z., Wu, X., Cai, X., Feng, S., Lu, J., Wang, H., & Liu, N. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0197 · Cited by 53
“org Mol Cancer Res; 17(10) October 2019 1977”
BackgroundInfluentialSun, N.-Y., & Yang, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00792 · Cited by 53
Li, J., Luo, G., Zhang, C., Long, S., Guo, L., Yang, G., Wang, F., Zhang, L., Shi, L., Fu, Y., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100238 · Cited by 54
“neuronal cadherin (N-cadherin) is a key adhesion protein in synaptogenesis and replaces E-cadherin during the EMT process thus contributing to tumor progression and metastasis [31].”
BackgroundAntitumor mechanisms when pRb and p53 are genetically inactivated
Zhu, L., Lu, Z., & Zhao, H.-T. (2014) · Oncogene · doi:10.1038/onc.2014.399 · Cited by 65
Zhou, C.-H., Zhao, J., Liu, J., Wei, S., Xia, Y., Xia, W., Bi, Y., Yan, Z., & Huang, H. (2019) · Cancer Biomarkers · doi:10.3233/cbm-190497 · Cited by 46
Mao, S., Zhang, W., Yang, F., Guo, Y., Wang, H., Wu, Y., Wang, R., Maskey, N., Zheng, Z., Cheng, L., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02138-8 · Cited by 48
Hashemi, M., Hajimazdarany, S., Mohan, C. D., Mohammadi, M., Rezaei, S., Olyaee, Y., Goldoost, Y., Ghorbani, A., Mirmazloomi, S. R., Gholinia, N., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106535 · Cited by 49
Glial Progenitors as Targets for Transformation in Glioma
Ilkhanizadeh, S., Lau, J., Huang, M., Foster, D. J., Wong, R. A., Frantz, A., Wang, S., Weiss, W. A., & Persson, A. I. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00001-9 · Cited by 52
“…phenotype is associated with increased activation of transforming growth factor beta (TGFβ) signaling, leading to increased expression of the transcription factor families of SNAIL, SLUG and TWIST, and downregulation of E-cadherin (Craene & Berx, 2013; Mallini, Lennard, Kirby, & Meeson, 2013).”
BackgroundUpadhyay, S. K., Verone, A. R., Shoemaker, S. F., Qin, M., Liu, S., Campbell, M. J., & Hershberger, P. A. (2013) · Cancers · doi:10.3390/cancers5041504 · Cited by 49
“Transcription factors belonging to the SNAIL and ZEB families coordinate EMT by repressing CDH1 and other cell junction proteins (reviewed in [16]).”
BackgroundGuo, W., You, X., Xu, D., Zhang, Y., Wang, Z., Man, K., Wang, Z., & Chen, Y. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw013 · Cited by 47
“These transcription factors execute EMT by repressing genes encoding epithelial-like proteins and activating mesenchymal genes (3,4).”
BackgroundEGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
Choudhary, K. S., Rohatgi, N., Halldórsson, S., Briem, E., Guðjónsson, Þ., Guðmundsson, S., & Rolfsson, Ó. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004924 · Cited by 47
“The D492M cells have high expression of N-cadherin and vimentin and low expression of E-cadherin that is typical for cells that have undergone EMT [34]. doi:10.1371/journal.pcbi.1004924.g001 PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004924 June 2, 2016 3 / 26 The EMT specific signaling network of D492 and…”
BackgroundInfluentialGlypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells
Castillo, L. F., Tascon, R. S., Huvelle, M. A. L., Novack, G. V., Llorens, M. C., dos Santos, A. F., Shortrede, J. E., Cabanillas, A. M., Joffé, E. B. D. K., Labriola, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11107 · Cited by 46
“On the other hand, EMT can be inhibited by p53, mesenchymal-epithelial (MET)-inducing transcription factors such as GRHL2 and ELF5, and microRNA (miR) families like miR-200 and miR-34 [8].”
BackgroundZhang, Z., Xu, C., Zhang, X., Huang, L., Zheng, C., Chen, H., Wang, Y., Ju, H., & Yao, Q. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14774897404770 · Cited by 46
Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load.
Holzapfel, N. P., Shokoohmand, A., Wagner, F., Landgraf, M., Champ, S., Holzapfel, B. M., Clements, J. A., Hutmacher, D. W., & Loessner, D. (2017) · PubMed · Cited by 63
Wu, D., Liu, T., Deng, S., Han, R., & Xu, Y. X. (2017) · Scientific Reports · doi:10.1038/s41598-017-07830-4 · Cited by 46
Chen, C., Ma, T., Zhang, C., Zhang, H., Bai, L., Kong, L., & Luo, J. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22712 · Cited by 47
“Mounting evidences have indicated that EMT is crucial in CRC metastasis.5,6 EMT is a process associated with significant changes in cell adhesion, migratory and invasive properties, and is typically characterized by up-regulation of mesenchymal markers such as N-cadherin, Vimentin, as well as down-regulation of epithe…”
BackgroundZhao, Y., Han, M., Xiong, Y., Wang, L., Fei, Y., Shen, X., Zhu, Y., & Liang, Z. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.164 · Cited by 47
Ortiz, R. C., Lopes, N. M., Amôr, N. G., Ponce, J., Schmerling, C. K., Lara, V. S., Moysés, R. A., & Rodini, C. O. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12734 · Cited by 59
Suda, K., Murakami, I., Yu, H., Kim, J., Tan, A.-C., Mizuuchi, H., Rozeboom, L., Ellison, K., Rivard, C. J., Mitsudomi, T., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1279 · Cited by 45
“EMT has long been recognized as playing amajor role in cancer progression and metastasis (23), as well as one of acquired resistance mechanisms to EGFR-TKIs (6, 7).”
BackgroundZhang, Z., Chen, J., Huang, W., Deng, N., Liu, Q., Wang, C., Zhang, L., Ren, L., Chu, L., Liang, H., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12429 · Cited by 48
“Therefore, discovery of the mechanisms underlying tumor progression is crucial to develop new strategies for the treatment of HCC. Epithelial-to-mesenchymal transition (EMT) plays an important role in embryonic development as well as the motility and metastasis of tumor cells (De and Berx, 2013).”
BackgroundZhang, J., Zhu, Y., Hu, L., Fang, Y., & Chen, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-43731-4 · Cited by 50
Fu, J., Xu, Y., Yang, Y., Liu, Y., Ma, L., & Zhang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-53276-1 · Cited by 53
Long non-coding RNA in bladder cancer
Cao, Y., Tian, T., Li, W., Xu, H., Zhan, C., Wu, X., Wang, C., Wu, X., Wu, W., Zheng, S., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.008 · Cited by 50
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
Cao, Z., Qiu, J., Yang, G., Liu, Y., Luo, W., You, L., Zheng, L., & Zhang, T. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0033 · Cited by 46
Zheng, X., Dai, F., Feng, L., Zou, H., Li, F., & Xu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617597 · Cited by 54
Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition.
Bai, Y., Wang, X., Cai, M., Ma, C., Xiang, Y., Hu, W., Zhou, B., Zhao, C., Dai, X., Li, X., et al. (2021) · American Journal of Cancer Research · Cited by 52
Xu, Y., Li, W., Lin, S., Liu, B., Wu, P., & Li, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01204-2 · Cited by 55
“Other cell types, such as epithelial cells [30], pericytes [31], monocytes [32], endothelial cells [33], mesothelial cells [34], hematopoietic stem cells [35], circulating bone marrow cells [36], and smooth muscle cells [37], are also reported as potential CAF precursors.”
BackgroundNeumann, D., Pillman, K. A., Dredge, B. K., Bert, A. G., Phillips, C. A., Lumb, R., Ramani, Y., Bracken, C. P., Hollier, B. G., Selth, L. A., et al. (2023) · RNA Biology · doi:10.1080/15476286.2023.2294222 · Cited by 55
“EMT can be initiated by extracellular cues that regulate extensive changes in gene transcription through induction of EMT transcription factors [2].”
Hj, L., Yu, P.-N., Huang, K.-Y., Su, H.-Y., Hsiao, T.-H., Chang, C.-P., Yu, M.-H., & Lin, Y.-W. (2015) · Oncogene · doi:10.1038/onc.2015.289 · Cited by 49
Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape
Nabet, B., Ó Broin, P., Reyes, J. M., Shieh, K., Lin, C. Y., Will, C. M., Popovic, R., Ezponda, T., Bradner, J. E., Golden, A. A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.078 · Cited by 46
“Significant enrichment of binding sites for TFs such as TWIST1 (p 0.01) was detected upon HRasG12V-transformation, consistent with the known role of oncogenic Ras in regulating and cooperating with Twist1 in oncogenesis (De Craene and Berx, 2013).”
InfluentialFluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells
Liu, S., Zhou, F., Shen, Y., Zhang, Y., Yin, H., Zeng, Y., Liu, J., Yan, Z., & Liu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8765 · Cited by 46
“com/oncotarget cytoplasm to nuclei [8].”
Voena, C., Varesio, L. M., Zhang, L., Menotti, M., Poggio, T., Panizza, E., Wang, Q., Minero, V. G., Fagoonee, S., Compagno, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8955 · Cited by 46
“EMT is mainly regulated by a complex network of transcription factors that potently induce the repression of E-cadherin and other junctional proteins, such as claudins and desmosomes [21, 22, 42].”
BackgroundInfluentialHu, Q., Wang, K., Sun, X. D., Li, Y., Fu, Q., Liang, T., & Tang, G. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.016 · Cited by 45
Han, H., & Hsu, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.014 · Cited by 49
“On the other hand, we also analyzed the expression of several EMT repressors (E-cadherin, ETS-related transcription factors ELF3 and ELF5, and grainyhead-like protein 2 homologue (GRHL2) [52,53]) in A549 cells after co-culture with MSCs.”
BackgroundWei, S., Wang, L., Zhang, L., Li, B., Li, Z., Zhang, Q., Wang, J., Chen, L., Sun, G., Li, Q., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5239-z · Cited by 46
“Many zinc finger proteins are involved in EMT by binding to CDH1 promoter, such as SNAL1, SNAL2, ZEB1, ZEB2, and KLF8 [21].”
BackgroundHashimoto, A., Hashimoto, S., Sugino, H., Yoshikawa, A., Onodera, Y., Handa, H., Oikawa, T., & Sabe, H. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.60 · Cited by 52
da Silveira, W. A., Palma, P. V. B., Sicchieri, R. D., Villacis, R. A. R., Mandarano, L. R. M., de Oliveira, T. M. G., Antônio, H. M. R., de Andrade, J. M., Muglia, V. F., Rogatto, S. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02761-6 · Cited by 52
“A network organized around the TF families of SNAIL , ZEB and TWIST, is well known to be responsible for the epithelial-to-mesenchymal transition 18 (EMT), a process involved in metastasis and closely related to the bCSC phenotype 2, 5 .”
Zhang, Q., Yang, J., Bai, J., & Ren, J. (2018) · Cancer Science · doi:10.1111/cas.13520 · Cited by 45
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
Bednarczyk, R. B., Tuli, N. Y., Hanly, E. K., Rahoma, G. M. B., Maniyar, R. R., Mittelman, A., Geliebter, J., & Tiwari, R. K. (2018) · Oncotarget · doi:10.18632/oncotarget.24917 · Cited by 50
“MMP-9 (84, 92 kDa) and GAPDH (37 kDa) expression was evaluated using Western blots. can contribute to EMT [49, 50].”
MethodCo-optation of Tandem DNA Repeats for the Maintenance of Mesenchymal Identity
Balestrieri, C., Alfarano, G., Milan, M., Tosi, V., Prosperini, E., Nicoli, P., Palamidessi, A., Scita, G., Diaferia, G. R., & Natoli, G. (2018) · Cell · doi:10.1016/j.cell.2018.03.081 · Cited by 50
“…several transcriptional regulators and microRNAs (miRNAs) have been identified that enforce (e.g., ELF3/5, KLF5, GRHL2/3, miR-200) or suppress (e.g., SNAIL1/2, TWIST1/2, ZEB1) the maintenance of the epithelial state (De Craene and Berx, 2013; Lee et al., 2014; Sánchez-Tilló et al., 2012).”
Zhu, X., Li, Y., Zhao, S., & Zhao, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.076 · Cited by 45
Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition
Zañudo, J. G. T., Guinn, M. T., Farquhar, K. S., Szenk, M., Steinway, S. N., Balázsi, G., & Albert, R. (2019) · Physical Biology · doi:10.1088/1478-3975/aaffa1 · Cited by 50
“16 (2019) 031002 10 J Gómez Tejeda Zañudo et al In reality, we know that several signaling pathways and transcriptional programs can induce EMT (Xu et al 2009, De Craene and Berx 2013, Lamouille et al 2014).”
Circular RNA Vav3 sponges gga-miR-375 to promote epithelial-mesenchymal transition
Zhang, X., Yan, Y., Lin, W., Li, A., Zhang, H., Lei, X., Dai, Z., Li, X., Li, H., Chen, W., et al. (2019) · RNA Biology · doi:10.1080/15476286.2018.1564462 · Cited by 46
“The EMT is a highly conserved cellular program that is characterized by the phenotypic conversion of epithelial cells to mesenchymal cells and has more recently been proved to involve in cancer progression and metastasis [26].”
BackgroundWang, X., Yin, G.-Q., Zhang, Z., Rong, Z., Wang, Z., Du, D., Wang, Y.-D., Gao, R.-X., & Xian, G. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111713 · Cited by 46
Lu, E., Hu, X., Pan, C., Chen, J., Xu, Y., & Zhu, X. (2019) · Journal of Cancer · doi:10.7150/jca.37147 · Cited by 46
Guo, X., Dai, X., Liu, J., Cheng, A., Qin, C., & Wang, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.026 · Cited by 49
“EMT, which is characterized by the loss of epithelial features and the acquisition of mesenchymal features, is a key step in cancer metastasis.(30,31) The markers of EMT in GC are associated with poor patient outcomes.”
BackgroundVuoso, D. C., D’Angelo, S., Ferraro, R., Caserta, S., Guido, S., Cammarota, M., Porcelli, M., & Cacciapuoti, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-73092-2 · Cited by 48
Ren, Y., Qiu, L., Lu, F.-L., Ru, X., Li, S., Xiang, Y., Yu, S., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep23775 · Cited by 51
De, S., Das, S., Mukherjee, S., Das, S., & Sengupta, S. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.10.005 · Cited by 44
Chen, X., YAN, H. H., Chen, Y., Guo, L., Yue, B., & Zhou, X. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-04034-9 · Cited by 46
Zhou, S., Pan, S., Qin, Y., Zhou, Z.-W., He, Z., Zhang, X., Yang, T., Yang, Y., Wang, D., & Qiu, J.-X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s89621 · Cited by 44
“We found that PLB significantly reduced the expression level of snail, slug, TCF-8/ZEB1, β -catenin, and vimentin, while increasing the expression level of claudin-1 and ZO-1.”
InfluentialmiRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
Samuel, P., Pink, R. C., Brooks, S. A., & Carter, D. R. F. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1121107 · Cited by 47
“EMT is a reversible process that is regulated by key transcription factors, including ZEB1, SNAI1 and Twist1.[111] Interestingly, the process of EMT has also been associated with the acquisition of drug resistance.”
BackgroundInfluentialMicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu, Z., Jin, Z., Liu, C., Xie, F., Lin, X., & Huang, Q. (2015) · PubMed Central · Cited by 44
Takaishi, M., Tarutani, M., Takeda, J., & Sano, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156904 · Cited by 44
“A major characteristic of EMT is the functional loss of the adherence junction protein, E-cadherin (CDH1), through multiple mechanisms, including gene mutation, hypermethylation, and repression of its promoter [1, 3, 4].”
TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research
Yokobori, T., & Nishiyama, M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010011 · Cited by 44
“EMT is an important cellular process that is associated with embryonic development, fibrosis, and tumorigenesis along with other diseases [18,19].”
Background
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.